Nan Shan Life Insurance’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50,000
Closed -$4.49M 105
2021
Q4
$4.49M Hold
50,000
0.07% 93
2021
Q3
$3.87M Hold
50,000
0.06% 95
2021
Q2
$3.58M Hold
50,000
0.06% 100
2021
Q1
$3.39M Hold
50,000
0.07% 113
2020
Q4
$3.66M Hold
50,000
0.08% 113
2020
Q3
$3.5M Hold
50,000
0.09% 97
2020
Q2
$3.64M Hold
50,000
0.11% 90
2020
Q1
$3.09M Sell
50,000
-75,928
-60% -$4.64M 0.11% 81
2019
Q4
$8.24M Sell
125,928
-1,055,557
-89% -$72.5M 0.26% 61
2019
Q3
$93.5M Sell
1,181,485
-646,877
-35% -$43.2M 2.57% 10
2019
Q2
$106M Sell
1,828,362
-289,896
-14% -$17M 2.7% 8
2019
Q1
$111M Sell
2,118,258
-113,235
-5% -$5.92M 2.19% 15
2018
Q4
$118M Buy
2,231,493
+624,159
+39% +$35.7M 2.82% 8
2018
Q3
$102M Buy
1,607,334
+548,138
+52% +$35.5M 1.98% 15
2018
Q2
$61.8M Buy
1,059,196
+86,685
+9% +$4.7M 1.43% 21
2018
Q1
$49.8M Buy
972,511
+194,534
+25% +$10.4M 1.02% 28
2017
Q4
$46.3M Buy
+777,977
New +$47.2M 1.2% 26

Other funds holding CONE

Nan Shan Life Insurance's CONE Position: Q1 2022 in Review

Nan Shan Life Insurance sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 50,000 shares — an estimated $4.49M sold.

Nan Shan Life Insurance first reported a position in CONE in Q4 2017 and held it in 17 quarters. The position peaked at $118M in Q4 2018. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Nan Shan Life Insurance reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Nan Shan Life Insurance sold 50,000 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $4.49M.
  • Nan Shan Life Insurance first reported a position in CyrusOne Inc Common Stock in Q4 2017 and held it in 17 quarters.
  • Nan Shan Life Insurance's CyrusOne Inc Common Stock position peaked at $118M in Q4 2018.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Nan Shan Life Insurance's 13F filing for Q1 2022, filed 13 May 2022.